First Tracks Biotherapeutics, Inc. (TRAX) vs Vir Biotechnology, Inc. (VIR)
- First Tracks Biotherapeutics, Inc. TRAX 47.78 +5.17%
- Vir Biotechnology, Inc. VIR 12.19 +10.62%
First Tracks Biotherapeutics, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. First Tracks Biotherapeutics, Inc. and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.9B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −61.0%) and the higher return on invested capital (0.00% vs −30.3%). Across the 10 metrics below, First Tracks Biotherapeutics, Inc. leads on 8 and Vir Biotechnology, Inc. on 2.
Valuation
Profitability
| Metric | TRAX | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 99.99% | 68.51% |
| Operating margin | 0.00% | (69.82%) | 0.00% |
| Net margin | 0.00% | (61.03%) | 0.00% |
| Free cash flow margin | 0.00% | (46.87%) | 0.00% |
| Return on equity | 0.00% | (21.84%) | (51.96%) |
| Return on assets | 0.00% | (17.34%) | (46.06%) |
| Return on invested capital | 0.00% | (30.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack